Genes and sex hormones interaction in neurodevelopmental disorders

Neuroscience and Biobehavioral Reviews

Volumn 67, Issue , 2016, Pages 9-24

  Romano, Emilia ^a   Cosentino, Livia ^a   Laviola, Giovanni ^a   De Filippis, Bianca ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Androgen; Animal models; Behavior; Estradiol; Estrogens; FMRP; MeCP2; Neuroactive steroids; Reelin; Trisomy 21

Indexed keywords

ANDROGEN; CYCLIN DEPENDENT KINASE 5; ESTRADIOL; ESTROGEN; FRAGILE X MENTAL RETARDATION PROTEIN; METHYL CPG BINDING PROTEIN 2; NEUROSTEROID; REELIN; RETINOID RELATED ORPHAN RECEPTOR ALPHA; SEX HORMONE; TESTOSTERONE;

AUTISM; BRAIN DEVELOPMENT; CDKL5 GENE; DOWN SYNDROME; EPIGENETICS; FMR1 GENE; FRAGILE X SYNDROME; GENE EXPRESSION; GENE MUTATION; HAPPY PUPPET SYNDROME; HEREDITY; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MECP2 GENE; MENTAL DISEASE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REELIN GENE; RETT SYNDROME; REVIEW; RORA GENE; SEX DIFFERENCE; SEX RATIO; SIGNAL TRANSDUCTION; TRISOMY 21; ANIMAL; METABOLISM;

ANIMALS; AUTISTIC DISORDER; GONADAL STEROID HORMONES; HUMANS; RETT SYNDROME;

EID: 84961815202     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.02.019     Document Type: Review

References (199)

1. A.P.A., 2013. Diagnostic and Statistical Manual of Mental Disorders (DSM-5, 5th edition).
2. Amendola, E., Zhan, Y., Mattucci, C., Castroflorio, E., Calcagno, E., Fuchs, C., Lonetti, G., Silingardi, D., Vyssotski, A.L., Farley, D., Ciani, E., Pizzorusso, T., Giustetto, M., Gross, C.T., Mapping pathological phenotypes in a mouse model of CDKL5 disorder. PLoS One, 9, 2014, e91613.
3. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., Zoghbi, H.Y., Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 (1999), 185–188.
4. Arnold, A.P., Sex chromosomes and brain gender. Nat. Rev. Neurosci. 5 (2004), 701–708.
5. Arnold, A.P., The organizational–activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav. 55 (2009), 570–578.
6. Auger, C.J., Coss, D., Auger, A.P., Forbes-Lorman, R.M., Epigenetic control of vasopressin expression is maintained by steroid hormones in the adult male rat brain. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 4242–4247.
7. Bagatin, E., Kamamoto, C.S., Guadanhim, L.R., Sanudo, A., Dias, M.C., Barraviera, I.M., Colombo, F.C., Prevalence of acne vulgaris in patients with Down syndrome. Dermatology 220 (2010), 333–339.
8. Bahi-Buisson, N., Bienvenu, T., CDKL5-related disorders: from clinical description to molecular genetics. Mol. Syndromol. 2 (2012), 137–152.
9. Baker, K.B., Wray, S.P., Ritter, R., Mason, S., Lanthorn, T.H., Savelieva, K.V., Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments. Genes Brain Behav. 9 (2010), 562–574.
10. Bakker, C.E., Verheij, C., Willemsen, R., van der Helm, R., Oerlemans, F., Vermey, M., Bygrave, A., Hoogeveen, A.T., Oostra, B.A.O., Fmr1 knockout mice: a model to study Fragile X mental retardation. The Dutch–Belgian Fragile X Consortium. Cell 78 (1994), 23–33.
11. Balemans, M.C., Huibers, M.M., Eikelenboom, N.W., Kuipers, A.J., van Summeren, R.C., Pijpers, M.M., Tachibana, M., Shinkai, Y., van Bokhoven, H., Van der Zee, C.E., Reduced exploration, increased anxiety, and altered social behavior: autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice. Behav. Brain Res. 208 (2010), 47–55.
12. Baron-Cohen, S., The extreme male brain theory of autism. Trends Cogn. Sci. 6 (2002), 248–254.
13. Baron-Cohen, S., Auyeung, B., Norgaard-Pedersen, B., Hougaard, D.M., Abdallah, M.W., Melgaard, L., Cohen, A.S., Chakrabarti, B., Ruta, L., Lombardo, M.V., Elevated fetal steroidogenic activity in autism. Mol. Psychiatry 20 (2015), 369–376.
14. Baron-Cohen, S., Lombardo, M.V., Auyeung, B., Ashwin, E., Chakrabarti, B., Knickmeyer, R., Why are autism spectrum conditions more prevalent in males?. PLoS Biol., 9, 2011, e1001081.
15. Belichenko, N.P., Belichenko, P.V., Mobley, W.C., Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol. Dis. 34 (2009), 71–77.
16. Belichenko, P.V., Kleschevnikov, A.M., Becker, A., Wagner, G.E., Lysenko, L.V., Yu, Y.E., Mobley, W.C., Down syndrome cognitive phenotypes modeled in mice trisomic for all HSA 21homologues. PLoS One, 10, 2015, e0134861.
17. Berkel, S., Marshall, C.R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., Bonin, M., Riess, A., Engels, H., Sprengel, R., Scherer, S.W., Rappold, G.A., Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42 (2010), 489–491.
18. Berman, R.F., Pessah, I.N., Mouton, P.R., Mav, D., Harry, J., Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Toxicol. Sci. 101 (2008), 294–309.
19. Biamonte, F., Assenza, G., Marino, R., D'Amelio, M., Panteri, R., Caruso, D., Scurati, S., Yague, J.G., Garcia-Segura, L.M., Cesa, R., Strata, P., Melcangi, R.C., Keller, F., Interactions between neuroactive steroids and reelin haploinsufficiency in Purkinje cell survival. Neurobiol. Dis. 36 (2009), 103–115.
20. Bielsky, I.F., Hu, S.B., Szegda, K.L., Westphal, H., Young, L.J., Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 29 (2004), 483–493.
21. Bourdon, V., Philippe, C., Martin, D., Verloes, A., Grandemenge, A., Jonveaux, P., MECP2 mutations or polymorphisms in mentally retarded boys: diagnostic implications. Mol. Diagn. 7 (2003), 3–7.
22. Brandt, N., Vierk, R., Rune, G.M., Sexual dimorphism in estrogen-induced synaptogenesis in the adult hippocampus. Int. J. Dev. Biol. 57 (2013), 351–356.
23. Chadwick, L.H., Wade, P.A., MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein?. Curr. Opin. Genet. Dev. 17 (2007), 121–125.
24. Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J., Zoghbi, H.Y., MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320 (2008), 1224–1229.
25. Chahrour, M., Zoghbi, H.Y., The story of Rett syndrome: from clinic to neurobiology. Neuron 56 (2007), 422–437.
26. Cheh, M.A., Millonig, J.H., Roselli, L.M., Ming, X., Jacobsen, E., Kamdar, S., Wagner, G.C., En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res. 1116 (2006), 166–176.
27. Chen, Q., Zhu, Y.C., Yu, J., Miao, S., Zheng, J., Xu, L., Zhou, Y., Li, D., Zhang, C., Tao, J., Xiong, Z.Q., CDKL5, a protein associated with rett syndrome, regulates neuronal morphogenesis via Rac1 signaling. J. Neurosci. 30 (2010), 12777–12786.
28. Cohen, S., Gabel, H.W., Hemberg, M., Hutchinson, A.N., Sadacca, L.A., Ebert, D.H., Harmin, D.A., Greenberg, R.S., Verdine, V.K., Zhou, Z., Wetsel, W.C., West, A.E., Greenberg, M.E., Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72 (2011), 72–85.
29. Costa, A.C., Walsh, K., Davisson, M.T., Motor dysfunction in a mouse model for Down syndrome. Physiol. Behav. 68 (1999), 211–220.
30. Crider, A., Thakkar, R., Ahmed, A.O., Pillai, A., Dysregulation of estrogen receptor beta (ERbeta), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects. Mol. Autism, 5, 2014, 46.
31. Das, I., Park, J.M., Shin, J.H., Jeon, S.K., Lorenzi, H., Linden, D.J., Worley, P.F., Reeves, R.H., Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. Sci. Trans. Med., 5, 2013 201ra120.
32. Davies, W., Wilkinson, L.S., It is not all hormones: alternative explanations for sexual differentiation of the brain. Brain Res. 1126 (2006), 36–45.
33. De Filippis, B., Chiodi, V., Adriani, W., Lacivita, E., Mallozzi, C., Leopoldo, M., Domenici, M.R., Fuso, A., Laviola, G., Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome. Front. Behav. Neurosci., 9, 2015, 86.
34. De Filippis, B., Fabbri, A., Simone, D., Canese, R., Ricceri, L., Malchiodi-Albedi, F., Laviola, G., Fiorentini, C., Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome. Neuropsychopharmacology 37 (2012), 1152–1163.
35. De Filippis, B., Fabbri, A., Simone, D., Canese, R., Ricceri, L., Malchiodi, F., Fiorentini, C., Laviola, G., Improvement of behavioral phenotype and astrocytic function in a mouse model of Rett syndrome: Effects of the Rho GTPase-modulating protein CNF1. 2nd European Rett Syndrome Conference, Edimburgh, UK, 2010, 213–223.
36. De Filippis, B., Musto, M., Altabella, L., Romano, E., Canese, R., Laviola, G., Deficient purposeful use of forepaws in female mice modelling Rett syndrome. Neural Plast., 2015, 326184.
37. De Filippis, B., Valenti, D., Chiodi, V., Ferrante, A., de Bari, L., Fiorentini, C., Domenici, M.R., Ricceri, L., Vacca, R.A., Fabbri, A., Laviola, G., Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome. Eur. Neuropsychopharmacol. 25 (2015), 889–901.
38. de Miguel-Diez, J., Villa-Asensi, J.R., Alvarez-Sala, J.L., Prevalence of sleep-disordered breathing in children with Down syndrome: polygraphic findings in 108 children. Sleep 26 (2003), 1006–1009.
39. Dean, S.L., McCarthy, M.M., Steroids, sex and the cerebellar cortex: implications for human disease. Cerebellum 7 (2008), 38–47.
40. Defensor, E.B., Pearson, B.L., Pobbe, R.L., Bolivar, V.J., Blanchard, D.C., Blanchard, R.J., A novel social proximity test suggests patterns of social avoidance and gaze aversion-like behavior in BTBR T+ tf/J mice. Behav. Brain Res. 217 (2011), 302–308.
41. DeLorey, T.M., Sahbaie, P., Hashemi, E., Homanics, G.E., Clark, J.D., Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav. Brain Res. 187 (2008), 207–220.
42. Ding, Q., Sethna, F., Wang, H., Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background. Behav. Brain Res. 271 (2014), 72–78.
43. Dufour-Rainfray, D., Vourc'h, P., Tourlet, S., Guilloteau, D., Chalon, S., Andres, C.R., Fetal exposure to teratogens: evidence of genes involved in autism. Neurosci. Biobehav. Rev. 35 (2010), 1254–1265.
44. Faizi, M., Bader, P.L., Tun, C., Encarnacion, A., Kleschevnikov, A., Belichenko, P., Saw, N., Priestley, M., Tsien, R.W., Mobley, W.C., Shamloo, M., Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of beta1-adrenergic receptor by xamoterol as a potential cognitive enhancer. Neurobiol. Dis. 43 (2011), 397–413.
45. Fernandez, F., Garner, C.C., Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome. Neurosci. Lett. 421 (2007), 137–141.
46. Ferrando Lucas, M.T., Banus Gomez, P., Lopez Perez, G., Cognitive aspects in girls with fragile X syndrome. Rev. Neurol. 38:Suppl 1 (2004), S53–S57.
47. Fombonne, E., Epidemiology of autistic disorder and other pervasive developmental disorders. J. Clin. Psychiatry 66:Suppl. 10 (2005), 3–8.
48. Forbes-Lorman, R.M., Kurian, J.R., Auger, A.P., MeCP2 regulates GFAP expression within the developing brain. Brain Res. 1543 (2014), 151–158.
49. Forbes-Lorman, R.M., Rautio, J.J., Kurian, J.R., Auger, A.P., Auger, C.J., Neonatal MeCP2 is important for the organization of sex differences in vasopressin expression. Epigenetics 7 (2012), 230–238.
50. Freeman, S.B., Bean, L.H., Allen, E.G., Tinker, S.W., Locke, A.E., Druschel, C., Hobbs, C.A., Romitti, P.A., Royle, M.H., Torfs, C.P., Dooley, K.J., Sherman, S.L., Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet. Med. 10 (2008), 173–180.
51. Galante, M., Jani, H., Vanes, L., Daniel, H., Fisher, E.M., Tybulewicz, V.L., Bliss, T.V., Morice, E., Impairments in motor coordination without major changes in cerebellar plasticity in the Tc1 mouse model of Down syndrome. Hum. Mol. Genet. 18 (2009), 1449–1463.
52. Garber, K.B., Visootsak, J., Warren, S.T., Fragile X syndrome. Eur. J. Hum. Genet. 16 (2008), 666–672.
53. Geier, D.A., Geier, M.R., A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuroendocrinol. Lett. 28 (2007), 565–573.
54. Glasson, E.J., Sullivan, S.G., Hussain, R., Petterson, B.A., Montgomery, P.D., Bittles, A.H., Comparative survival advantage of males with Down syndrome. Am. J. Hum. Biol. 15 (2003), 192–195.
55. Gonzalez-Aguero, A., Vicente-Rodriguez, G., Moreno, L.A., Casajus, J.A., Bone mass in male and female children and adolescents with Down syndrome. Osteoporos. Int. 22 (2011), 2151–2157.
56. Gore, A.C., Martien, K.M., Gagnidze, K., Pfaff, D., Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism. Endocr. Rev. 35 (2014), 961–991.
57. Granholm, A.C., Ford, K.A., Hyde, L.A., Bimonte, H.A., Hunter, C.L., Nelson, M., Albeck, D., Sanders, L.A., Mufson, E.J., Crnic, L.S., Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome. Physiol. Behav. 77 (2002), 371–385.
58. Granholm, A.C., Sanders, L., Seo, H., Lin, L., Ford, K., Isacson, O., Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Hippocampus 13 (2003), 905–914.
59. Guy, J., Cheval, H., Selfridge, J., Bird, A., The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 27 (2011), 631–652.
60. Hagberg, B., Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8 (2002), 61–65.
61. Hagberg, B., Aicardi, J., Dias, K., Ramos, O., A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14 (1983), 471–479.
62. Hagerman, R.J., Sobesky, W.E., Psychopathology in fragile X syndrome. Am. J. Orthopsychiatry 59 (1989), 142–152.
63. Hall, S.S., Lightbody, A.A., McCarthy, B.E., Parker, K.J., Reiss, A.L., Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology 37 (2012), 509–518.
64. Hamilton, S.M., Green, J.R., Veeraragavan, S., Yuva, L., McCoy, A., Wu, Y., Warren, J., Little, L., Ji, D., Cui, X., Weinstein, E., Paylor, R., Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders. Behav. Neurosci. 128 (2014), 103–109.
65. Hamilton, S.M., Spencer, C.M., Harrison, W.R., Yuva-Paylor, L.A., Graham, D.F., Daza, R.A., Hevner, R.F., Overbeek, P.A., Paylor, R., Multiple autism-like behaviors in a novel transgenic mouse model. Behav. Brain Res. 218 (2011), 29–41.
66. Hassold, T., Abruzzo, M., Adkins, K., Griffin, D., Merrill, M., Millie, E., Saker, D., Shen, J., Zaragoza, M., Human aneuploidy: incidence, origin, and etiology. Environ. Mol. Mutagen. 28 (1996), 167–175.
67. Heller, H.C., Salehi, A., Chuluun, B., Das, D., Lin, B., Moghadam, S., Garner, C.C., Colas, D., Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors. Neurobiol. Learn. Mem. 116 (2014), 162–171.
68. Hestnes, A., Stovner, L.J., Husoy, O., Folling, I., Fougner, K.J., Sjaastad, O., Hormonal and biochemical disturbances in Down's syndrome. J. Ment. Defic. Res. 35:Pt 3 (1991), 179–193.
69. Hill, S.K., Beers, S.R., Kmiec, J.A., Keshavan, M.S., Sweeney, J.A., Impairment of verbal memory and learning in antipsychotic-naive patients with first-episode schizophrenia. Schizophr. Res. 68 (2004), 127–136.
70. Hohmann, C.F., Walker, E.M., Boylan, C.B., Blue, M.E., Neonatal serotonin depletion alters behavioral responses to spatial change and novelty. Brain Res. 1139 (2007), 163–177.
71. Hotchkiss, A.K., Ostby, J.S., Vandenburgh, J.G., Gray, L.E. Jr., Androgens and environmental antiandrogens affect reproductive development and play behavior in the Sprague–Dawley rat. Environ. Health Perspect. 110:Suppl 3 (2002), 435–439.
72. Hu, V.W., Sarachana, T., Sherrard, R.M., Kocher, K.M., Investigation of sex differences in the expression of RORA and its transcriptional targets in the brain as a potential contributor to the sex bias in autism. Mol. Autism, 6, 2015, 6.
73. Huerta-Ramos, E., Iniesta, R., Ochoa, S., Cobo, J., Miquel, E., Roca, M., Serrano-Blanco, A., Teba, F., Usall, J., Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. Eur. Neuropsychopharmacol. 24 (2014), 223–231.
74. Hunter, C.L., Bimonte-Nelson, H.A., Nelson, M., Eckman, C.B., Granholm, A.C., Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. Neurobiol. Aging 25 (2004), 873–884.
75. Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I.C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C., Bourgeron, T., Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34 (2003), 27–29.
76. Jamain, S., Radyushkin, K., Hammerschmidt, K., Granon, S., Boretius, S., Varoqueaux, F., Ramanantsoa, N., Gallego, J., Ronnenberg, A., Winter, D., Frahm, J., Fischer, J., Bourgeron, T., Ehrenreich, H., Brose, N., Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 1710–1715.
77. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N., Strouboulis, J., Wolffe, A.P., Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19 (1998), 187–191.
78. Katz, D.M., Berger-Sweeney, J.E., Eubanks, J.H., Justice, M.J., Neul, J.L., Pozzo-Miller, L., Blue, M.E., Christian, D., Crawley, J.N., Giustetto, M., Guy, J., Howell, C.J., Kron, M., Nelson, S.B., Samaco, R.C., Schaevitz, L.R., St Hillaire-Clarke, C., Young, J.L., Zoghbi, H.Y., Mamounas, L.A., Preclinical research in Rett syndrome: setting the foundation for translational success. Dis. Models Mech. 5 (2012), 733–745.
79. Kazdoba, T.M., Leach, P.T., Silverman, J.L., Crawley, J.N., Modeling fragile X syndrome in the Fmr1 knockout mouse. Intractable Rare Dis. Res. 3 (2014), 118–133.
80. Kelemenova, S., Schmidtova, E., Ficek, A., Celec, P., Kubranska, A., Ostatnikova, D., Polymorphisms of candidate genes in Slovak autistic patients. Psychiatr. Genet. 20 (2010), 137–139.
81. Keller, F., Ruta, L., The malep revalence in autism spectrum disorders: hypotheses on its neurobiological basis. Blatt, G.J., (eds.) The Neurochemical Basis of Autism, 2010, Springer, Verlag.
82. Kilstrup-Nielsen, C., Rusconi, L., La Montanara, P., Ciceri, D., Bergo, A., Bedogni, F., Landsberger, N., What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy. Neural Plast., 2012 728267.
83. Kim, H.G., Kishikawa, S., Higgins, A.W., Seong, I.S., Donovan, D.J., Shen, Y., Lally, E., Weiss, L.A., Najm, J., Kutsche, K., Descartes, M., Holt, L., Braddock, S., Troxell, R., Kaplan, L., Volkmar, F., Klin, A., Tsatsanis, K., Harris, D.J., Noens, I., Pauls, D.L., Daly, M.J., MacDonald, M.E., Morton, C.C., Quade, B.J., Gusella, J.F., Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 82 (2008), 199–207.
84. Kleschevnikov, A.M., Belichenko, P.V., Faizi, M., Jacobs, L.F., Htun, K., Shamloo, M., Mobley, W.C., Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. J. Neurosci. 32 (2012), 9217–9227.
85. Knickmeyer, R., Baron-Cohen, S., Raggatt, P., Taylor, K., Foetal testosterone, social relationships, and restricted interests in children. J. Child Psychol. Psychiatry 46 (2005), 198–210.
86. Knickmeyer, R.C., Baron-Cohen, S., Fetal testosterone and sex differences in typical social development and in autism. J. Child Neurol. 21 (2006), 825–845.
87. Kokras, N., Dalla, C., Sex differences in animal models of psychiatric disorders. Br. J. Pharmacol. 171 (2014), 4595–4619.
88. Kovaleva, N.V., Butomo, I.V., Korblein, A., Sex ratio in Down syndrome: Studies in patients with confirmed trisomy 21. Tsitol. Genet. 35 (2001), 43–49.
89. Krause, I., He, X.S., Gershwin, M.E., Shoenfeld, Y., Brief report: immune factors in autism: a critical review. J. Autism Dev. Disord. 32 (2002), 337–345.
90. Kulkarni, J., Berk, M., Wang, W., Mu, L., Scarr, E., Van Rheenen, T.E., Worsley, R., Gurvich, C., Gavrilidis, E., de Castella, A., Fitzgerald, P., Davis, S.R., A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania. Psychoneuroendocrinology 43 (2014), 52–61.
91. Kulkarni, J., Gavrilidis, E., Worsley, R., Van Rheenen, T., Hayes, E., The role of estrogen in the treatment of men with schizophrenia. Int. J. Endocrinol. Metab. 11 (2013), 129–136.
92. Kurian, J.R., Bychowski, M.E., Forbes-Lorman, R.M., Auger, C.J., Auger, A.P., Mecp2 organizes juvenile social behavior in a sex-specific manner. J. Neurosci. 28 (2008), 7137–7142.
93. Kurian, J.R., Forbes-Lorman, R.M., Auger, A.P., Sex difference in mecp2 expression during a critical period of rat brain development. Epigenetics 2 (2007), 173–178.
94. Lai, F., Kammann, E., Rebeck, G.W., Anderson, A., Chen, Y., Nixon, R.A., APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome. Neurology 53 (1999), 331–336.
95. Lai, M.C., Baron-Cohen, S., Buxbaum, J.D., Understanding autism in the light of sex/gender. Mol Autism, 6, 2015, 24.
96. Lai, M.C., Lombardo, M.V., Auyeung, B., Chakrabarti, B., Baron-Cohen, S., Sex/gender differences and autism: setting the scene for future research. J. Am. Acad. Child Adolesc. Psychiatry 54 (2015), 11–24.
97. Lai, M.C., Lombardo, M.V., Suckling, J., Ruigrok, A.N., Chakrabarti, B., Ecker, C., Deoni, S.C., Craig, M.C., Murphy, D.G., Bullmore, E.T., Baron-Cohen, S., Biological sex affects the neurobiology of autism. Brain 136 (2013), 2799–2815.
98. Lalonde, R., Hayzoun, K., Derer, M., Mariani, J., Strazielle, C., Neurobehavioral evaluation of Reln-rl-orl mutant mice and correlations with cytochrome oxidase activity. Neurosci. Res. 49:3 (2004), 297–305.
99. Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A., Moizard, M.P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P., Laudier, B., Chelly, J., Fryns, J.P., Ropers, H.H., Hamel, B.C., Andres, C., Barthelemy, C., Moraine, C., Briault, S., X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 74 (2004), 552–557.
100. Laviola, G., Ognibene, E., Romano, E., Adriani, W., Keller, F., Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modelling of major neurobehavioral syndromes. Neurosci. Biobehav. Rev. 33 (2009), 560–572.
101. Levav-Rabkin, T., Blumkin, E., Galron, D., Golan, H.M., Sex-dependent behavioral effects of Mthfr deficiency and neonatal GABA potentiation in mice. Behav. Brain Res. 216 (2011), 505–513.
102. Lijam, N., Paylor, R., McDonald, M.P., Crawley, J.N., Deng, C.X., Herrup, K., Stevens, K.E., Maccaferri, G., McBain, C.J., Sussman, D.J., Wynshaw-Boris, A., Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90 (1997), 895–905.
103. Lintas, C., Persico, A.M., Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J. Med. Genet. 46 (2009), 1–8.
104. Loesch, D.Z., Huggins, R.M., Hagerman, R.J., Phenotypic variation and FMRP levels in fragile X. Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004), 31–41.
105. Maatta, T., Tervo-Maatta, T., Taanila, A., Kaski, M., Iivanainen, M., Mental health, behaviour and intellectual abilities of people with Down syndrome. Downs Syndr. Res. Pract. 11 (2006), 37–43.
106. Macri, S., Biamonte, F., Romano, E., Marino, R., Keller, F., Laviola, G., Perseverative responding and neuroanatomical alterations in adult heterozygous reeler mice are mitigated by neonatal estrogen administration. Psychoneuroendocrinology 35 (2010), 1374–1387.
107. Martinez-Cue, C., Baamonde, C., Lumbreras, M., Paz, J., Davisson, M.T., Schmidt, C., Dierssen, M., Florez, J., Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome. Behav. Brain Res. 134 (2002), 185–200.
108. Matsuda, K.I., Mori, H., Kawata, M., Epigenetic mechanisms are involved in sexual differentiation of the brain. Rev. Endocr. Metab. Disord. 13 (2012), 163–171.
109. McBride, S.M., Choi, C.H., Wang, Y., Liebelt, D., Braunstein, E., Ferreiro, D., Sehgal, A., Siwicki, K.K., Dockendorff, T.C., Nguyen, H.T., McDonald, T.V., Jongens, T.A., Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45 (2005), 753–764.
110. McBride, S.M., Holloway, S.L., Jongens, T.A., Using as a tool to identify Pharmacological Therapies for Fragile X Syndrome. Drug Discov. Today Technol. 10 (2012), e129–e136.
111. McCarthy, M.M., Arnold, A.P., Reframing sexual differentiation of the brain. Nat. Neurosci. 14 (2011), 677–683.
112. McCarthy, M.M., Konkle, A.T., When is a sex difference not a sex difference?. Front. Neuroendocrinol. 26 (2005), 85–102.
113. McCarthy, M.M., Nugent, B.M., At the frontier of epigenetics of brain sex differences. Front. Behav. Neurosci., 9, 2015, 221.
114. McCarthy, M.M., Schwarz, J.M., Wright, C.L., Dean, S.L., Mechanisms mediating oestradiol modulation of the developing brain. J. Neuroendocrinol. 20 (2008), 777–783.
115. McFarlane, H.G., Kusek, G.K., Yang, M., Phoenix, J.L., Bolivar, V.J., Crawley, J.N., Autism-like behavioral phenotypes in BTBR T + tf/J mice. Genes Brain Behav. 7 (2008), 152–163.
116. McGill, B.E., Bundle, S.F., Yaylaoglu, M.B., Carson, J.P., Thaller, C., Zoghbi, H.Y., Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 18267–18272.
117. McKinney, W.T., Animal models of depression: an overview. Psychiatr. Dev. 2 (1984), 77–96.
118. Miller, W.L., Molecular biology of steroid hormone synthesis. Endocr. Rev. 9 (1988), 295–318.
119. Moessner, R., Marshall, C.R., Sutcliffe, J.S., Skaug, J., Pinto, D., Vincent, J., Zwaigenbaum, L., Fernandez, B., Roberts, W., Szatmari, P., Scherer, S.W., Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81 (2007), 1289–1297.
120. Moog, U., Smeets, E.E., van Roozendaal, K.E., Schoenmakers, S., Herbergs, J., Schoonbrood-Lenssen, A.M., Schrander-Stumpel, C.T., Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur. J. Paediatr. Neurol. 7 (2003), 5–12.
121. Moretti, P., Bouwknecht, J.A., Teague, R., Paylor, R., Zoghbi, H.Y., Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 14 (2005), 205–220.
122. Morice, E., Andreae, L.C., Cooke, S.F., Vanes, L., Fisher, E.M., Tybulewicz, V.L., Bliss, T.V., Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learn. Mem. 15 (2008), 492–500.
123. Mottron, L., Duret, P., Mueller, S., Moore, R.D., Forgeot d'Arc, B., Jacquemont, S., Xiong, L., Sex differences in brain plasticity: a new hypothesis for sex ratio bias in autism. Mol. Autism, 6, 2015, 33.
124. Mount, R.H., Hastings, R.P., Reilly, S., Cass, H., Charman, T., Behavioural and emotional features in Rett syndrome. Disabil. Rehabil. 23 (2001), 129–138.
125. Nakatani, J., Tamada, K., Hatanaka, F., Ise, S., Ohta, H., Inoue, K., Tomonaga, S., Watanabe, Y., Chung, Y.J., Banerjee, R., Iwamoto, K., Kato, T., Okazawa, M., Yamauchi, K., Tanda, K., Takao, K., Miyakawa, T., Bradley, A., Takumi, T., Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137 (2009), 1235–1246.
126. Ognibene, E., Adriani, W., Granstrem, O., Pieretti, S., Laviola, G., Impulsivity-anxiety-related behavior and profiles of morphine-induced analgesia in heterozygous reeler mice. Brain Res. 1131 (2007), 173–180.
127. Palomba, S., Marotta, R., Di Cello, A., Russo, T., Falbo, A., Orio, F., Tolino, A., Zullo, F., Esposito, R., La Sala, G.B., Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. Clin. Endocrinol. (Oxf.) 77 (2012), 898–904.
128. Patel, B.N., Seltzer, G.B., Wu, H.S., Schupf, N., Effect of menopause on cognitive performance in women with Down syndrome. Neuroreport 12 (2001), 2659–2662.
129. Patterson, P.H., Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr. Opin. Neurobiol. 12 (2002), 115–118.
130. Phoenix, C.H., Goy, R.W., Gerall, A.A., Young, W.C., Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology 65 (1959), 369–382.
131. Prasad, S., Singh, K., Testosterone down regulates the expression of Fmr-1 gene in the cerebral cortex of gonadectomized old male mice. Biogerontology 15 (2014), 503–515.
132. Prendergast, B.J., Onishi, K.G., Zucker, I., Female mice liberated for inclusion in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 40 (2014), 1–5.
133. Qin, M., Kang, J., Smith, C.B., A null mutation for Fmr1 in female mice: effects on regional cerebral metabolic rate for glucose and relationship to behavior. Neuroscience 135 (2005), 999–1009.
134. Radyushkin, K., Hammerschmidt, K., Boretius, S., Varoqueaux, F., El-Kordi, A., Ronnenberg, A., Winter, D., Frahm, J., Fischer, J., Brose, N., Ehrenreich, H., Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav. 8 (2009), 416–425.
135. Reiss, A.L., Freund, L., Fragile X syndrome. Biol. Psychiatry 27 (1990), 223–240.
136. Reiss, A.L., Hagerman, R.J., Vinogradov, S., Abrams, M., King, R.J., Psychiatric disability in female carriers of the fragile X chromosome. Arch. Gen. Psychiatry 45 (1988), 25–30.
137. Renieri, A., Meloni, I., Longo, I., Ariani, F., Mari, F., Pescucci, C., Cambi, F., Rett syndrome: the complex nature of a monogenic disease. J. Mol. Med. (Berl.) 81 (2003), 346–354.
138. Rett, A., On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien. Med. Wochenschr. 116 (1966), 723–726.
139. Ricceri, L., De Filippis, B., Laviola, G., Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav. Pharmacol. 19 (2008), 501–517.
140. Ricceri, L., De Filippis, B., Laviola, G., Rett syndrome treatment in mouse models: searching for effective targets and strategies. Neuropharmacology 68 (2013), 106–115.
141. Ricciardi, S., Ungaro, F., Hambrock, M., Rademacher, N., Stefanelli, G., Brambilla, D., Sessa, A., Magagnotti, C., Bachi, A., Giarda, E., Verpelli, C., Kilstrup-Nielsen, C., Sala, C., Kalscheuer, V.M., Broccoli, V., CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. Nat. Cell Biol. 14 (2012), 911–923.
142. Robel, P., Baulieu, E.E., Neurosteroids biosynthesis and function. Trends Endocrinol. Metab. 5 (1994), 1–8.
143. Rotschafer, S.E., Trujillo, M.S., Dansie, L.E., Ethell, I.M., Razak, K.A., Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome. Brain Res. 1439 (2012), 7–14.
144. Rueda, N., Florez, J., Martinez-Cue, C., Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities. Neural Plast., 2012 584071.
145. Rusconi, L., Salvatoni, L., Giudici, L., Bertani, I., Kilstrup-Nielsen, C., Broccoli, V., Landsberger, N., CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J. Biol. Chem. 283 (2008), 30101–30111.
146. Russo, S., Marchi, M., Cogliati, F., Bonati, M.T., Pintaudi, M., Veneselli, E., Saletti, V., Balestrini, M., Ben-Zeev, B., Larizza, L., Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes. Neurogenetics 10 (2009), 241–250.
147. 2+ -dependent activator protein for secretion 2 and autistic-like phenotypes. Neurosci. Res. 67 (2010), 197–202.
148. Sadakata, T., Washida, M., Iwayama, Y., Shoji, S., Sato, Y., Ohkura, T., Katoh-Semba, R., Nakajima, M., Sekine, Y., Tanaka, M., Nakamura, K., Iwata, Y., Tsuchiya, K.J., Mori, N., Detera-Wadleigh, S.D., Ichikawa, H., Itohara, S., Yoshikawa, T., Furuichi, T., Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J. Clin. Invest. 117 (2007), 931–943.
149. Sago, H., Carlson, E.J., Smith, D.J., Kilbridge, J., Rubin, E.M., Mobley, W.C., Epstein, C.J., Huang, T.T., Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 6256–6261.
150. Sago, H., Carlson, E.J., Smith, D.J., Rubin, E.M., Crnic, L.S., Huang, T.T., Epstein, C.J., Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res. 48 (2000), 606–613.
151. Samaco, R.C., McGraw, C.M., Ward, C.S., Sun, Y., Neul, J.L., Zoghbi, H.Y., Female Mecp2(+/−) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum. Mol. Genet. 22 (2013), 96–109.
152. Santos, A.R., Kanellopoulos, A.K., Bagni, C., Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us. Learn. Mem. 21 (2014), 543–555.
153. Santos, M., Silva-Fernandes, A., Oliveira, P., Sousa, N., Maciel, P., Evidence for abnormal early development in a mouse model of Rett syndrome. Genes Brain Behav. 6 (2007), 277–286.
154. Sarachana, T., Xu, M., Wu, R.C., Hu, V.W., Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. PLoS One, 6, 2011, e17116.
155. Scala, E., Ariani, F., Mari, F., Caselli, R., Pescucci, C., Longo, I., Meloni, I., Giachino, D., Bruttini, M., Hayek, G., Zappella, M., Renieri, A., CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J. Med. Genet. 42 (2005), 103–107.
156. Scattoni, M.L., Ricceri, L., Crawley, J.N., Unusual repertoire of vocalizations in adult BTBR T + tf/J mice during three types of social encounters. Genes Brain Behav. 10 (2011), 44–56.
157. Schaafsma, S.M., Pfaff, D.W., Etiologies underlying sex differences in Autism Spectrum Disorders. Front. Neuroendocrinol. 35 (2014), 255–271.
158. Schaefer, T.L., Davenport, M.H., Erickson, C.A., Emerging pharmacologic treatment options for fragile X syndrome. Appl. Clin. Genet. 8 (2015), 75–93.
159. Schneider, T., Roman, A., Basta-Kaim, A., Kubera, M., Budziszewska, B., Schneider, K., Przewlocki, R., Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33 (2008), 728–740.
160. Schumacher, M., Weill-Engerer, S., Liere, P., Robert, F., Franklin, R.J., Garcia-Segura, L.M., Lambert, J.J., Mayo, W., Melcangi, R.C., Parducz, A., Suter, U., Carelli, C., Baulieu, E.E., Akwa, Y., Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71 (2003), 3–29.
161. Schupf, N., Kapell, D., Nightingale, B., Rodriguez, A., Tycko, B., Mayeux, R., Earlier onset of Alzheimer's disease in men with Down syndrome. Neurology 50 (1998), 991–995.
162. Schupf, N., Winsten, S., Patel, B., Pang, D., Ferin, M., Zigman, W.B., Silverman, W., Mayeux, R., Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome. Neurosci. Lett. 406 (2006), 298–302.
163. Schwarz, J.M., McCarthy, M.M., Cellular mechanisms of estradiol-mediated masculinization of the brain. J. Steroid Biochem. Mol. Biol. 109 (2008), 300–306.
164. Shahbazian, M.D., Antalffy, B., Armstrong, D.L., Zoghbi, H.Y., Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11 (2002), 115–124.
165. Sheng, L., Ding, X., Ferguson, M., McCallister, M., Rhoades, R., Maguire, M., Ramesh, A., Aschner, M., Campbell, D., Levitt, P., Hood, D.B., Prenatal polycyclic aromatic hydrocarbon exposure leads to behavioral deficits and downregulation of receptor tyrosine kinase, MET. Toxicol. Sci. 118 (2010), 625–634.
166. Shi, L., Fatemi, S.H., Sidwell, R.W., Patterson, P.H., Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23 (2003), 297–302.
167. Silverman, J.L., Yang, M., Lord, C., Crawley, J.N., Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11 (2010), 490–502.
168. Simpkins, J.W., Perez, E., Wang, X., Yang, S., Wen, Y., Singh, M., The potential for estrogens in preventing Alzheimer's disease and vascular dementia. Ther. Adv. Neurol. Disord. 2 (2009), 31–49.
169. Singh, K., Prasad, S., Age- and sex-related analysis of methylation of 5’-upstream sequences of Fmr-1 gene in mouse brain and modulation by sex steroid hormones. Biogerontology 9 (2008), 455–465.
170. Singh, K., Prasad, S., Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging. Mol. Biol. Rep. 35 (2008), 677–684.
171. Spencer, C.M., Alekseyenko, O., Hamilton, S.M., Thomas, A.M., Serysheva, E., Yuva-Paylor, L.A., Paylor, R., Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res. 4 (2011), 40–56.
172. Spencer, C.M., Alekseyenko, O., Serysheva, E., Yuva-Paylor, L.A., Paylor, R., Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav. 4 (2005), 420–430.
173. Stearns, N.A., Schaevitz, L.R., Bowling, H., Nag, N., Berger, U.V., Berger-Sweeney, J., Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome. Neuroscience 146 (2007), 907–921.
174. Stewart, L.S., Persinger, M.A., Cortez, M.A., Snead, O.C. 3rd, Chronobiometry of behavioral activity in the Ts65Dn model of Down syndrome. Behav. Genet. 37 (2007), 388–398.
175. Sultan, M., Piccini, I., Balzereit, D., Herwig, R., Saran, N.G., Lehrach, H., Reeves, R.H., Yaspo, M.L., Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biol., 8, 2007, R91.
176. Supekar, K., Menon, V., Sex differences in structural organization of motor systems and their dissociable links with repetitive/restricted behaviors in children with autism. Mol. Autism, 6, 2015, 50.
177. Suzuki, K., Nakajima, K., Kamimura, S., Takasugi, K., Suzuki, Y., Sekine, H., Ishii, N., Eight case reports on sex-hormone profiles in sexually mature male Down syndrome. Int. J. Urol. 17 (2010), 1008–1010.
178. Tabuchi, K., Blundell, J., Etherton, M.R., Hammer, R.E., Liu, X., Powell, C.M., Sudhof, T.C., A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318 (2007), 71–76.
179. Torres, A.R., Is fever suppression involved in the etiology of autism and neurodevelopmental disorders?. BMC Pediatr., 3, 2003, 9.
180. Tucker, B., Richards, R., Lardelli, M., Expression of three zebrafish orthologs of human FMR1-related genes and their phylogenetic relationships. Dev. Genes Evol. 214 (2004), 567–574.
181. Veeraragavan, S., Bui, N., Perkins, J.R., Yuva-Paylor, L.A., Carpenter, R.L., Paylor, R., Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome. Psychopharmacol. (Berl.) 217 (2014), 143–151.
182. Villard, L., MECP2 mutations in males. J. Med. Genet. 44 (2007), 417–423.
183. Vojdani, A., Pangborn, J.B., Vojdani, E., Cooper, E.L., Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16 (2003), 189–199.
184. Wang, I.T., Allen, M., Goffin, D., Zhu, X., Fairless, A.H., Brodkin, E.S., Siegel, S.J., Marsh, E.D., Blendy, J.A., Zhou, Z., Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 20516–21521.
185. Weickert, T.W., Weinberg, D., Lenroot, R., Catts, S.V., Wells, R., Vercammen, A., O'Donnell, M., Galletly, C., Liu, D., Balzan, R., Short, B., Pellen, D., Curtis, J., Carr, V.J., Kulkarni, J., Schofield, P.R., Weickert, C.S., Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Mol. Psychiatry 20 (2015), 685–694.
186. Werling, D.M., Geschwind, D.H., Sex differences in autism spectrum disorders. Curr. Opin. Neurol. 26 (2013), 146–153.
187. Witton, J., Padmashri, R., Zinyuk, L.E., Popov, V.I., Kraev, I., Line, S.J., Jensen, T.P., Tedoldi, A., Cummings, D.M., Tybulewicz, V.L., Fisher, E.M., Bannerman, D.M., Randall, A.D., Brown, J.T., Edwards, F.A., Rusakov, D.A., Stewart, M.G., Jones, M.W., Hippocampal circuit dysfunction in the Tc1 mouse model of Down syndrome. Nat. Neurosci. 18 (2015), 1291–1298.
188. Wolstenholme, J.T., Rissman, E.F., Bekiranov, S., Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes. Genes Brain Behav. 12 (2013), 166–180.
189. Woods, R., Vallero, R.O., Golub, M.S., Suarez, J.K., Ta, T.A., Yasui, D.H., Chi, L.H., Kostyniak, P.J., Pessah, I.N., Berman, R.F., LaSalle, J.M., Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. Hum. Mol. Genet. 21 (2012), 2399–2411.
190. Wu, M.V., Manoli, D.S., Fraser, E.J., Coats, J.K., Tollkuhn, J., Honda, S., Harada, N., Shah, N.M., Estrogen masculinizes neural pathways and sex-specific behaviors. Cell 139 (2009), 61–72.
191. Xu, X.J., Zhang, H.F., Shou, X.J., Li, J., Jing, W.L., Zhou, Y., Qian, Y., Han, S.P., Zhang, R., Han, J.S., Prenatal hyperandrogenic environment induced autistic-like behavior in rat offspring. Physiol. Behav. 138 (2015), 13–20.
192. Yang, M., Abrams, D.N., Zhang, J.Y., Weber, M.D., Katz, A.M., Clarke, A.M., Silverman, J.L., Crawley, J.N., Low sociability in BTBR T + tf/J mice is independent of partner strain. Physiol. Behav. 107 (2012), 649–662.
193. Yang, Q., Yang, L., Zhang, K., Guo, Y.Y., Liu, S.B., Wu, Y.M., Li, X.Q., Song, Q., Zhuo, M., Zhao, M.G., Increased coupling of caveolin-1 and estrogen receptor alpha contributes to the fragile X syndrome. Ann. Neurol. 77 (2015), 618–636.
194. Yochum, C.L., Bhattacharya, P., Patti, L., Mirochnitchenko, O., Wagner, G.C., Animal model of autism using GSTM1 knockout mice and early post-natal sodium valproate treatment. Behav. Brain Res. 210 (2010), 202–210.
195. Yu, T., Liu, C., Belichenko, P., Clapcote, S.J., Li, S., Pao, A., Kleschevnikov, A., Bechard, A.R., Asrar, S., Chen, R., Fan, N., Zhou, Z., Jia, Z., Chen, C., Roder, J.C., Liu, B., Baldini, A., Mobley, W.C., Yu, Y.E., Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res. 1366 (2010), 162–171.
196. Zaccaria, K.J., Lagace, D.C., Eisch, A.J., McCasland, J.S., Resistance to change and vulnerability to stress: autistic-like features of GAP43-deficient mice. Genes Brain Behav. 9 (2010), 985–996.
197. Zampieri, B.L., Fernandez, F., Pearson, J.N., Stasko, M.R., Costa, A.C., Ultrasonic vocalizations during male-female interaction in the mouse model of Down syndrome Ts65Dn. Physiol. Behav. 128 (2014), 119–125.
198. Zhao, Y., Fung, C., Shin, D., Shin, B.C., Thamotharan, S., Sankar, R., Ehninger, D., Silva, A., Devaskar, S.U., Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders. Mol. Psychiatry. 15 (2010), 286–299.
199. Zhu, X.W., Pan, H., Li, M.R., Bao, X.H., Zhang, J.J., Wu, X.R., Analysis of the parental origin of de novo MECP2 mutations and X chromosome inactivation in fifteen sporadic cases with Rett syndrome. Zhonghua Er Ke Za Zhi 47 (2009), 565–569.